25 related articles for article (PubMed ID: 12579350)
1.
Kulpa-Eddy J; Srinivas G; Halder M; Hill R; Brown K; Roth J; Draayer H; Galvin J; Claassen I; Gifford G; Woodland R; Doelling V; Jones B; Stokes WS
Procedia Vaccinol; 2011; 5():60-83. PubMed ID: 32288914
[TBL] [Abstract][Full Text] [Related]
2. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
Cussler K; Balks E
ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
[TBL] [Abstract][Full Text] [Related]
3. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
Beckmann R; Gyra H; Cussler K
Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
[No Abstract] [Full Text] [Related]
4. Oral vaccination against swine erysipelas--field experiences in Croatia.
Hoffmann CR; Bilkei G
Dtsch Tierarztl Wochenschr; 2006 Jan; 113(1):13-5. PubMed ID: 16475549
[TBL] [Abstract][Full Text] [Related]
5. Erysipelas immunizing product review.
Bairey MH; Vogel JH
Proc Annu Meet U S Anim Health Assoc; 1973; (77):340-4. PubMed ID: 4534722
[No Abstract] [Full Text] [Related]
6. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test.
Rosskopf-Streicher U; Johannes S; Wilhelm M; Cussler K
Vaccine; 2001 Jan; 19(11-12):1477-83. PubMed ID: 11163671
[TBL] [Abstract][Full Text] [Related]
7. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
[TBL] [Abstract][Full Text] [Related]
8. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
Cussler K; Borrmann E; Werner E
Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
[TBL] [Abstract][Full Text] [Related]
9. Swine erysipelas--a review of prevalence and research.
Wood RL
J Am Vet Med Assoc; 1984 Apr; 184(8):944-9. PubMed ID: 6370938
[No Abstract] [Full Text] [Related]
10. Humane endpoints for laboratory animals used in regulatory testing.
Stokes WS
ILAR J; 2002; 43 Suppl():S31-8. PubMed ID: 12388849
[TBL] [Abstract][Full Text] [Related]
11. Refinement of vaccine potency testing with the use of humane endpoints.
Hendriksen CF; Steen B
ILAR J; 2000; 41(2):105-13. PubMed ID: 11417495
[No Abstract] [Full Text] [Related]
12. Humane regulatory testing: the United Kingdom experience.
Richmond JD
Altern Lab Anim; 2004 Jun; 32 Suppl 1A():355-8. PubMed ID: 23577486
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
